Metformin Hydrochloride — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Metformin Hydrochloride. We track 120 distinct Drug Identification Numbers (DINs) for this molecule, of which 60 are currently in marketed status. Across those registrations there are 31 manufacturers or marketing authorization holders, 2 dosage forms, and 14 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Metformin Hydrochloride in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Metformin Hydrochloride product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Metformin Hydrochloride
Dosage forms: Tablet, Tablet (Extended-Release). Strengths: 850 MG, 500 MG, 50 MG, 5 MG, 1000 MG, 100 MG, 4.00 MG, 1 MG, 4 MG, 2 MG, 2.00 MG, 150 MG, 2.5 MG, 12.5 MG.
Manufacturers and marketing authorization holders
ACCEL PHARMA INC, ACCORD HEALTHCARE INC, ANGITA PHARMA INC., APOTEX INC, AURO PHARMA INC, AVANSTRA INC, GLAXOSMITHKLINE INC, BAKER CUMMINS INC, BIOMED PHARMA, DOMINION PHARMACAL, ECL PHARMA GROUP LTD, GLENMARK PHARMACEUTICALS CANADA INC., SANOFI-AVENTIS CANADA INC, BAUSCH HEALTH, CANADA INC., STRIDES PHARMA CANADA INC, JANSSEN INC, MARCAN PHARMACEUTICALS INC, JAMP PHARMA CORPORATION, MERCK CANADA INC, BOEHRINGER INGELHEIM (CANADA) LTD LTEE, and others.
Registered products containing Metformin Hydrochloride
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 02409291 | ACC-METFORMIN | ACCEL PHARMA INC | 850 MG | Tablet | Cancelled Pre Market |
| 02406020 | ACH-METFORMIN | ACCORD HEALTHCARE INC | 500 MG | Tablet | Cancelled Pre Market |
| 02406039 | ACH-METFORMIN | ACCORD HEALTHCARE INC | 850 MG | Tablet | Cancelled Pre Market |
| 02494418 | AG-METFORMIN | ANGITA PHARMA INC. | 500 MG | Tablet | Marketed |
| 02494442 | AG-METFORMIN | ANGITA PHARMA INC. | 850 MG | Tablet | Marketed |
| 02557711 | AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN | ANGITA PHARMA INC. | 50 MG | Tablet | Marketed |
| 02557738 | AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN | ANGITA PHARMA INC. | 50 MG | Tablet | Marketed |
| 02557746 | AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN | ANGITA PHARMA INC. | 50 MG | Tablet | Marketed |
| 02536153 | APO-DAPAGLIFLOZIN-METFORMIN | APOTEX INC | 5 MG | Tablet | Marketed |
| 02536161 | APO-DAPAGLIFLOZIN-METFORMIN | APOTEX INC | 5 MG | Tablet | Marketed |
| 02229785 | APO-METFORMIN | APOTEX INC | 850 MG | Tablet | Dormant |
| 02167786 | APO-METFORMIN | APOTEX INC | 500 MG | Tablet | Dormant |
| 02305062 | APO-METFORMIN ER | APOTEX INC | 500 MG | Tablet (Extended-Release) | Marketed |
| 02460653 | APO-METFORMIN ER | APOTEX INC | 1000 MG | Tablet (Extended-Release) | Marketed |
| 02509431 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | 50 MG | Tablet | Marketed |
| 02509423 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | 50 MG | Tablet | Marketed |
| 02509415 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | 50 MG | Tablet | Marketed |
| 02435772 | APO-SITAGLIPTIN-METFORMIN | APOTEX INC | 50 MG | Tablet | Marketed |
| 02435780 | APO-SITAGLIPTIN-METFORMIN | APOTEX INC | 50 MG | Tablet | Marketed |
| 02435799 | APO-SITAGLIPTIN-METFORMIN | APOTEX INC | 50 MG | Tablet | Marketed |
| 02506289 | APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | 50 MG | Tablet (Extended-Release) | Marketed |
| 02506297 | APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | 100 MG | Tablet (Extended-Release) | Marketed |
| 02506270 | APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | 50 MG | Tablet (Extended-Release) | Marketed |
| 02533073 | AURO-DAPAGLIFLOZIN / METFORMIN | AURO PHARMA INC | 5 MG | Tablet | Marketed |
| 02533081 | AURO-DAPAGLIFLOZIN / METFORMIN | AURO PHARMA INC | 5 MG | Tablet | Marketed |
| 02438283 | AURO-METFORMIN | AURO PHARMA INC | 850 MG | Tablet | Marketed |
| 02438275 | AURO-METFORMIN | AURO PHARMA INC | 500 MG | Tablet | Marketed |
| 02547805 | AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | AURO PHARMA INC | 50 MG | Tablet | Marketed |
| 02547821 | AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | AURO PHARMA INC | 50 MG | Tablet | Marketed |
| 02547813 | AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | AURO PHARMA INC | 50 MG | Tablet | Marketed |
| 02364506 | AVA-METFORMIN | AVANSTRA INC | 500 MG | Tablet | Cancelled Post Market |
| 02364514 | AVA-METFORMIN | AVANSTRA INC | 850 MG | Tablet | Cancelled Post Market |
| 02248441 | AVANDAMET | GLAXOSMITHKLINE INC | 4.00 MG | Tablet | Cancelled Post Market |
| 02247085 | AVANDAMET | GLAXOSMITHKLINE INC | 1 MG | Tablet | Cancelled Post Market |
| 02247087 | AVANDAMET | GLAXOSMITHKLINE INC | 4 MG | Tablet | Cancelled Post Market |
| 02247086 | AVANDAMET | GLAXOSMITHKLINE INC | 2 MG | Tablet | Cancelled Post Market |
| 02248440 | AVANDAMET | GLAXOSMITHKLINE INC | 2.00 MG | Tablet | Cancelled Post Market |
| 02265583 | BCI METFORMIN | BAKER CUMMINS INC | 850 MG | Tablet | Cancelled Post Market |
| 02265575 | BCI METFORMIN | BAKER CUMMINS INC | 500 MG | Tablet | Cancelled Post Market |
| 02564270 | BIO-METFORMIN | BIOMED PHARMA | 850 MG | Tablet | Approved |
| 02564262 | BIO-METFORMIN | BIOMED PHARMA | 500 MG | Tablet | Approved |
| 02449331 | BIO-METFORMIN | BIOMED PHARMA | 850 MG | Tablet | Cancelled Pre Market |
| 02449323 | BIO-METFORMIN | BIOMED PHARMA | 500 MG | Tablet | Cancelled Pre Market |
| 02242726 | DOM-METFORMIN | DOMINION PHARMACAL | 850 MG | Tablet | Cancelled Post Market |
| 02229994 | DOM-METFORMIN | DOMINION PHARMACAL | 500 MG | Tablet | Cancelled Post Market |
| 02421836 | ECL-METFORMIN | ECL PHARMA GROUP LTD | 850 MG | Tablet | Cancelled (Unreturned Annual) |
| 02421828 | ECL-METFORMIN | ECL PHARMA GROUP LTD | 500 MG | Tablet | Cancelled (Unreturned Annual) |
| 02572273 | GLN-METFORMIN XR | GLENMARK PHARMACEUTICALS CANADA INC. | 1000 MG | Tablet (Extended-Release) | Approved |
| 02162849 | GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | 850 MG | Tablet | Cancelled Post Market |
| 02099233 | GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | 500 MG | Tablet | Marketed |
| 02446065 | GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | 1000 MG | Tablet | Cancelled Pre Market |
| 02300451 | GLUMETZA | BAUSCH HEALTH, CANADA INC. | 1000 MG | Tablet (Extended-Release) | Marketed |
| 02268493 | GLUMETZA | BAUSCH HEALTH, CANADA INC. | 500 MG | Tablet (Extended-Release) | Marketed |
| 02268507 | GLUMETZA (SB) | BAUSCH HEALTH, CANADA INC. | 1000 MG | Tablet (Extended-Release) | Approved |
| 02239214 | GLYCON | BAUSCH HEALTH, CANADA INC. | 850 MG | Tablet | Dormant |
| 02229516 | GLYCON | BAUSCH HEALTH, CANADA INC. | 500 MG | Tablet | Dormant |
| 02463601 | GPC-METFORMIN XR | STRIDES PHARMA CANADA INC | 500 MG | Tablet (Extended-Release) | Approved |
| 02463628 | GPC-METFORMIN XR | STRIDES PHARMA CANADA INC | 1000 MG | Tablet (Extended-Release) | Approved |
| 02455420 | INVOKAMET | JANSSEN INC | 50 MG | Tablet | Marketed |
| 02455447 | INVOKAMET | JANSSEN INC | 150 MG | Tablet | Cancelled Post Market |
| 02455455 | INVOKAMET | JANSSEN INC | 150 MG | Tablet | Marketed |
| 02455404 | INVOKAMET | JANSSEN INC | 50 MG | Tablet | Marketed |
| 02455439 | INVOKAMET | JANSSEN INC | 150 MG | Tablet | Cancelled Post Market |
| 02455412 | INVOKAMET | JANSSEN INC | 50 MG | Tablet | Cancelled Post Market |
| 02477424 | INVOKAMET XR | JANSSEN INC | 150 MG | Tablet (Extended-Release) | Cancelled Pre Market |
| 02477408 | INVOKAMET XR | JANSSEN INC | 50 MG | Tablet (Extended-Release) | Cancelled Pre Market |
| 02477394 | INVOKAMET XR | JANSSEN INC | 50 MG | Tablet (Extended-Release) | Cancelled Pre Market |
| 02477416 | INVOKAMET XR | JANSSEN INC | 150 MG | Tablet (Extended-Release) | Cancelled Pre Market |
| 02378051 | IPG-METFORMIN | MARCAN PHARMACEUTICALS INC | 850 MG | Tablet | Approved |
| 02378043 | IPG-METFORMIN | MARCAN PHARMACEUTICALS INC | 500 MG | Tablet | Approved |
| 02380196 | JAMP METFORMIN | JAMP PHARMA CORPORATION | 500 MG | Tablet | Marketed |
| 02380218 | JAMP METFORMIN | JAMP PHARMA CORPORATION | 850 MG | Tablet | Marketed |
| 02556200 | JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN | JAMP PHARMA CORPORATION | 50 MG | Tablet | Marketed |
| 02556189 | JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN | JAMP PHARMA CORPORATION | 50 MG | Tablet | Marketed |
| 02556197 | JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN | JAMP PHARMA CORPORATION | 50 MG | Tablet | Marketed |
| 02380730 | JAMP-METFORMIN BLACKBERRY | JAMP PHARMA CORPORATION | 850 MG | Tablet | Cancelled Post Market |
| 02380722 | JAMP-METFORMIN BLACKBERRY | JAMP PHARMA CORPORATION | 500 MG | Tablet | Cancelled Post Market |
| 02333856 | JANUMET | MERCK CANADA INC | 50 MG | Tablet | Marketed |
| 02333872 | JANUMET | MERCK CANADA INC | 50 MG | Tablet | Marketed |
| 02333864 | JANUMET | MERCK CANADA INC | 50 MG | Tablet | Cancelled Post Market |
| 02416808 | JANUMET XR | MERCK CANADA INC | 100 MG | Tablet (Extended-Release) | Marketed |
| 02416794 | JANUMET XR | MERCK CANADA INC | 50 MG | Tablet (Extended-Release) | Marketed |
| 02416786 | JANUMET XR | MERCK CANADA INC | 50 MG | Tablet (Extended-Release) | Marketed |
| 02403269 | JENTADUETO | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 2.5 MG | Tablet | Marketed |
| 02403250 | JENTADUETO | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 500 MG | Tablet | Marketed |
| 02403277 | JENTADUETO | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | 2.5 MG | Tablet | Marketed |
| 02417235 | KAZANO | TAKEDA CANADA INC | 12.5 MG | Tablet | Marketed |
| 02417219 | KAZANO | TAKEDA CANADA INC | 12.5 MG | Tablet | Marketed |
| 02417227 | KAZANO | TAKEDA CANADA INC | 12.5 MG | Tablet | Marketed |
| 02389177 | KOMBOGLYZE | ASTRAZENECA CANADA INC | 2.5 MG | Tablet | Cancelled Post Market |
| 02389169 | KOMBOGLYZE | ASTRAZENECA CANADA INC | 2.5 MG | Tablet | Cancelled Post Market |
| 02389185 | KOMBOGLYZE | ASTRAZENECA CANADA INC | 2.5 MG | Tablet | Cancelled Post Market |
| 02547767 | M-METFORMIN | MANTRA PHARMA INC | 500 MG | Tablet | Marketed |
| 02548275 | M-METFORMIN | MANTRA PHARMA INC | 1000 MG | Tablet | Marketed |
| 02547775 | M-METFORMIN | MANTRA PHARMA INC | 850 MG | Tablet | Marketed |
| 02551853 | M-METFORMIN XR | MANTRA PHARMA INC | 1000 MG | Tablet (Extended-Release) | Marketed |
| 02551845 | M-METFORMIN XR | MANTRA PHARMA INC | 500 MG | Tablet (Extended-Release) | Marketed |
| 02570602 | M-SITAGLIPTIN-METFORMIN | MANTRA PHARMA INC | 50 MG | Tablet | Approved |
| 02570629 | M-SITAGLIPTIN-METFORMIN | MANTRA PHARMA INC | 50 MG | Tablet | Approved |
| 02570610 | M-SITAGLIPTIN-METFORMIN | MANTRA PHARMA INC | 50 MG | Tablet | Approved |
Sourcing Metformin Hydrochloride through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Metformin Hydrochloride we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Metformin Hydrochloride and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.